Abstract:<p>Recent advances in structural biology and computational techniques have revealed allosteric mechanisms for an abundance of targets leading to the establishment of rational design of allosteric modulators as a new avenue for drug discovery. Considering that allostery is an intrinsic property of the protein conformational ensemble, allosteric drug design has the potential to develop into an innovative approach to modulate the dysregulation of therapeutic targets that are considered to be undruggable at their orthosteric site, explore strategic design opportunities to tackle new chemical space, or develop mutant-specific therapies to target mutations occurring far from the enzyme active site. Traditionally, allosteric drug discovery has been performed through high-throughput screening or through serendipitous discoveries; however, recent developments in structure-based and ligand-based methods have led to exciting advancements of designing bioactive allosteric ligands rationally. In this review article, we highlight the advantages and disadvantages of allosteric modulators and present structure-based and ligand-based drug design methodologies for the identification of allosteric binding sites and allosteric modulators. We also illustrate representative studies for the design allosteric modulators for proteins belonging to a wide range of protein families, also considering irreversible binding with covalent allosteric modulators. Additionally, we analyze challenges and successes in the rational design of allosteric inhibitors and activators. Finally, we present the future of rational allosteric ligand design with newly built computational tools that we expect to be applied in future studies, concluding to theoretical and practical guidelines for allosteric ligand design strategies and identify knowledge gaps that need to be addressed to improve efficiency in allosteric drug design.</p><p>This article is categorized under: </p><ul class="plain-list"><li>Structure and Mechanism > Computational Biochemistry and Biophysics</li><li>Structure and Mechanism > Molecular Structures</li></ul>

Designed covalent allosteric modulators: an emerging paradigm in drug discovery

Designed dualsteric modulators: A novel route for drug discovery

Rational design of allosteric modulators: Challenges and successes

Allosteric drugs: New principles and design approaches

Application of covalent modality in proximity-induced drug pharmacology: Early development, current strategy, and feature directions

Computational elucidation of allosteric communication in proteins for allosteric drug design

Advances in covalent drug discovery

Toward the Design of Allosteric Effectors: Gaining Comprehensive Control of Drug Properties and Actions

Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.

Landscape of In Silico Tools for Modeling Covalent Modification of Proteins: A Review on Computational Covalent Drug Discovery

Research progress of indole-fused derivatives as allosteric modulators: Opportunities for drug development

Covalent Inhibition in Drug Discovery

Allo-network drugs: harnessing allostery in cellular networks

Integrated Covalent Drug Design Workflow Using Site Identification by Ligand Competitive Saturation

Extended Applications of Small-Molecule Covalent Inhibitors toward Novel Therapeutic Targets

The value of protein allostery in rational anticancer drug design: an update

Harnessing Reversed Allosteric Communication: A Novel Strategy for Allosteric Drug Discovery

Applications of covalent chemistry in targeted protein degradation

Towards Covalent Organic Frameworks with Predesignable and Aligned Open Docking Sites

Combining Allosteric and Orthosteric Drugs to Overcome Drug Resistance

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with alpha-Substituent Electrophiles Targeting Cysteine